Email Us

Mycobacteria Nucleic Acid Detection CapitalBio

For the purpose of distinguishing between MTB and NTM, the real-time fluorescent PCR and TaqMan probe technologies are utilized. This kit is the only CFDA-approved PCR assay for rapidly separating MTB cases from those caused by other mycobacterium species.

mycobacteria nucleic acid detection

Features

  • Complete all tests within 3 hours

  • Simultaneous detection of MTB and NTM in a single sample

  • LoD: 10 CFU/reaction for MTB; 100 CFU/reaction for NTM

  • Specificity: 98.9%; and detection rates for bacterial-positive and negative pulmonary tuberculosis are 97% and 24.4%, respectively

Applicable Device

  • ABI 7700 real-time PCR system

  • ABI 7500 real-time PCR system

  • FQD-96A Fluorescent PCR Instrument

  • Eppendorf ® Mastercycler ® ep realplex 4 S Real-Time PCR System

Applications

Rapid screening for suspected tuberculosis cases

Differential diagnosis of MTB/NTM infectious

Diagnosis aid for TB in the lungs when bacteria are negative

Detection of MTB/NTM infectious in high-risk population, including: those in intimate contact with smear-positive patients, those with HIV infection or diabetes, and those taking biologics or immunosuppressants. Studies on disease prevalence

Specification

Order information

Cat. No.DescriptionSpecification
301031Mycobacteria Nucleic Acid Test Kit (PCR-Fluorescence Probe Method)20 tests/ kit


Products
Contact with CapitalBiotech
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing